XBIO

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 614.24 K648.82 K593.26 K589.9 K1.03 M 2.86 M Gross profit 614.24 K648.82 K593.26 K589.9 K1.03 M 2.86 M Operating expenses 1.11 M1.75 M1.54 M1.31 M1.57 M 6.17 M Selling/general/admin expenses 745.73 K705.71 K656.64 K657.75 K815.21 K 2.84 M Research & development 367.98 K1.04 M879.03 K656.56 K756.48 K 3.33 M Operating income -499.47 K-1.1 M-942.41 K-724.41 K-544.73 K -3.31 M Non-Operating Income, Total 62.8 K44.62 K39.27 K35.71 K34.79 K 154.4 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 61.3 K51.87 K39.19 K34.23 K30.78 K 156.07 K Unusual income/expense 1 504-7 243781 4774 011 -1 677 Pretax income -436.67 K-1.05 M-903.14 K-688.7 K-509.94 K -3.16 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -436.67 K-1.05 M-903.14 K-688.7 K-509.94 K -3.16 M Discontinued operations ————— — Net income -436.67 K-1.05 M-903.14 K-688.7 K-509.94 K -3.16 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -436.67 K-1.05 M-903.14 K-688.7 K-509.94 K -3.16 M Basic earnings per share (Basic EPS) -0.28-0.68-0.59-0.44-0.32 -2.03 Diluted earnings per share (Diluted EPS) -0.28-0.68-0.59-0.44-0.32 -2.03 Average basic shares outstanding 1.54 M1.54 M1.54 M1.54 M1.54 M 6.17 M Diluted shares outstanding 1.54 M1.54 M1.54 M1.54 M1.54 M 6.17 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —